All aspects of clinical trials present significant risk. The Trialytics approach mitigates these risks and reduces waste by applying an evidence base of healthcare data to clinical trials strategies. Our approaches markedly reduce the risks, time and cost of protocol design, site selection and patient recruitment.

According to CenterWatch, approximately 94% of clinical trials conducted in the USA are delayed. Typical factors causing delays include poor site performance and lack of effective recruitment methods. In the USA there are too few research sites, causing overuse of many known investigators. At Trialytics we leverage electronic healthcare data to redefine clinical trial strategies and to mitigate these factors. Using proprietary algorithms, Trialytics harnesses this data to assist in the development and execution of clinical trials in phases II, III, and post-marketing studies.

Trialytics specializes in applying advanced analytics of healthcare data to clinical development strategies to optimize protocol designs, mitigate the risks of site selection, locate the right patients and drive patient recruitment at the local level through primary care pathways.